2021
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
Mougalian SS, Kish JK, Zhang J, Liassou D, Feinberg BA. Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States. Advances In Therapy 2021, 38: 3487-3487. PMID: 33993427, DOI: 10.1007/s12325-021-01780-0.Peer-Reviewed Original ResearchCorrection to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
Mougalian SS, Kish JK, Zhang J, Liassou D, Feinberg BA. Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States. Advances In Therapy 2021, 38: 2226-2228. PMID: 33826091, PMCID: PMC8107069, DOI: 10.1007/s12325-021-01683-0.Peer-Reviewed Original Research
2020
Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer
Pusztai L, Taylor R, Mougalian SS. Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer. Cancer Cell 2020, 38: 323-325. PMID: 32931742, DOI: 10.1016/j.ccell.2020.08.006.Peer-Reviewed Original Research